Previous studies demonstrated that high density of CD8+ T cells in tumor center (TC) as well as invasive margin (IM) was associated with good prognosis of patients with NSCLC, while some studies believed that CD8+T cells in different regions embodied inconsistent prognostic significance, suggesting that there were some unexpected causes [6–9]. The gene discussed is CD8A; the disease is non-small cell lung carcinoma.